Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04727216 · ClinicalTrials.gov registry record · NA

Intermittent vs. Continuous Dorsal Root Ganglion Stimulation

A NA study of Pain, Chronic and Pain, Intractable, sponsored by Spine and Pain Institute of New York.

Active
Registry status
NA
Development phase
15
Enrollment target
1
Study location

NCT04727216 is a NA study of Pain, Chronic and Pain, Intractable that is active but no longer recruiting, run by Spine and Pain Institute of New York. The registered enrollment target is 15 participants, below the 721-participant average among 48 other Pain, Chronic trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04727216, a NA study of Pain, Chronic and Pain, Intractable, is active but no longer recruiting, sponsored by Spine and Pain Institute of New York.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
15 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to evaluate and compare the therapeutic efficacy of intermittent Dorsal Root Ganglion Stimulation (DRG-S) to standard continuous stimulation in patients with chronic intractable pain

Interventions

  • DEVICE Dorsal Root Ganglion Stimulation (DRG-S)

Study Locations (1)

New York

  • Spine and Pain Institute NY - New York

Trial Details

FieldValue
Enrollment Target 15 participants
Start Date 2021-03-23
Est. Completion 2021-09-15
Phase NA

What the Registry Record Tells You About NCT04727216

The ClinicalTrials.gov registry entry for NCT04727216 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 15 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 721-participant average among 48 other Pain, Chronic trials with a reported enrollment target (98% lower). The listed sponsor is Spine and Pain Institute of New York, which has 1 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Pain, Chronic appearing as the primary indexed condition, and to 1 intervention - of which Dorsal Root Ganglion Stimulation (DRG-S) is the first listed.

NCT04727216 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.

Frequently Asked Questions

What is clinical trial NCT04727216 about?

NCT04727216 is a clinical study titled "Intermittent vs. Continuous Dorsal Root Ganglion Stimulation". The purpose of this study is to evaluate and compare the therapeutic efficacy of intermittent Dorsal Root Ganglion Stimulation (DRG-S) to standard continuous stimulation in patients with chronic intractable pain

What is the current status of trial NCT04727216?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 15 participants. The study started on 2021-03-23. Estimated completion is 2021-09-15.

What conditions does trial NCT04727216 study?

This clinical trial studies the following conditions: Pain, Chronic, Pain, Intractable.

What interventions are being tested in trial NCT04727216?

The interventions under investigation include: Dorsal Root Ganglion Stimulation (DRG-S) (DEVICE).

Who is sponsoring clinical trial NCT04727216?

This trial is sponsored by Spine and Pain Institute of New York, which has 1 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04727216 being conducted?

This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Pain, Chronic

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.